DCP
MRK icon

Distillate Capital Partners’s Merck MRK Stock Holding History

Distillate Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.8M Buy
446,915
+2,489
+0.6% +$287K 2.83% 2
2025
Q4 		$46.8M Sell
444,426
-113,557
-20% -$10.7M 2.41% 2
2025
Q3 		$46.8M Sell
557,983
-7,370
-1% -$607K 2.43% 3
2025
Q2 		$44.8M Sell
565,353
-58,061
-9% -$4.62M 2.4% 2
2025
Q1 		$56M Buy
+623,414
New +$58.2M 2.87% 2
2023
Q1 		– Sell
-113
Closed -$12.5K – 79
2022
Q4 		$12.5K Buy
+113
New +$11.6K 1.16% 15

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Distillate Capital Partners's MRK Position: Q1 2026 in Review

Distillate Capital Partners increased its Merck (MRK) stake by 0.56% in Q1 2026, buying an estimated $287K and bringing the position to 446,915 shares worth $53.8M. The position accounts for 2.83% of the portfolio, ranked #2.

Distillate Capital Partners first reported a position in MRK in Q4 2022 and has held it in 6 quarters since. The position peaked at $56M in Q1 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Distillate Capital Partners held 446,915 shares of Merck worth $53.8M as of Q1 2026.
  • Distillate Capital Partners bought 2,489 Merck shares in Q1 2026, an estimated $287K.
  • Merck made up 2.83% of Distillate Capital Partners's portfolio in Q1 2026, its #2 holding.
  • Distillate Capital Partners first reported a position in Merck in Q4 2022 and has held it in 6 quarters since.
  • Distillate Capital Partners's Merck position peaked at $56M in Q1 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Distillate Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.